Telehealthcare for asthma: a Cochrane review

  • Susannah McLean MBBS
  • Published 2011


lence of asthma in recent decades, and the Global Initiative for Asthma estimates that 300 million people worldwide now have the disease. The highest prevalence rates (30%) are seen in economically developed countries. There has also been an increase in the prevalence of asthma affecting both children and adults in many economically developing and transition countries. Asthma’s high burden of disease requires improvements in access to treatments. Patterns of help-seeking behaviour are also relevant: delayed reporting is associated with morbidity and the need for emergency care. It is widely believed that telehealthcare interventions may help address some of the challenges posed by asthma by enabling remote delivery of care, facilitating timely access to health advice, supporting self-monitoring and medication concordance, and educating patients on avoiding triggers. The precise role of these technologies in the management of care for people with long-term respiratory conditions needs to be established. The objective of this study was to systematically review the effectiveness of telehealthcare interventions among people with asthma in terms of quality of life, number of visits to the emergency department and admissions to hospital for exacerbations of asthma.

4 Figures and Tables

Cite this paper

@inproceedings{MBBS2011TelehealthcareFA, title={Telehealthcare for asthma: a Cochrane review}, author={Susannah McLean MBBS}, year={2011} }